Eli Lilly and Co
NYSE:LLY

Watchlist Manager
Eli Lilly and Co Logo
Eli Lilly and Co
NYSE:LLY
Watchlist
Price: 786.23 USD -3.15% Market Closed
Market Cap: 747.3B USD
Have any thoughts about
Eli Lilly and Co?
Write Note

Eli Lilly and Co
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Eli Lilly and Co
Capital Expenditures Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
ZTS

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Eli Lilly and Co
NYSE:LLY
Capital Expenditures
-$8.3B
CAGR 3-Years
-53%
CAGR 5-Years
-38%
CAGR 10-Years
-18%
Johnson & Johnson
NYSE:JNJ
Capital Expenditures
-$4.4B
CAGR 3-Years
-7%
CAGR 5-Years
-4%
CAGR 10-Years
-2%
Bristol-Myers Squibb Co
NYSE:BMY
Capital Expenditures
-$1.2B
CAGR 3-Years
-9%
CAGR 5-Years
-7%
CAGR 10-Years
-8%
Pfizer Inc
NYSE:PFE
Capital Expenditures
-$3.2B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
-7%
Merck & Co Inc
NYSE:MRK
Capital Expenditures
-$3.4B
CAGR 3-Years
10%
CAGR 5-Years
-1%
CAGR 10-Years
-11%
Zoetis Inc
NYSE:ZTS
Capital Expenditures
-$637m
CAGR 3-Years
-11%
CAGR 5-Years
-8%
CAGR 10-Years
-14%

See Also

What is Eli Lilly and Co's Capital Expenditures?
Capital Expenditures
-8.3B USD

Based on the financial report for Sep 30, 2024, Eli Lilly and Co's Capital Expenditures amounts to -8.3B USD.

What is Eli Lilly and Co's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-18%

Over the last year, the Capital Expenditures growth was -41%. The average annual Capital Expenditures growth rates for Eli Lilly and Co have been -53% over the past three years , -38% over the past five years , and -18% over the past ten years .

Back to Top